Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$36.8K Sell
12,282
-3,987
-25% -$14.2K ﹤0.01% 3781
2026
Q1
$51.6K Buy
+16,269
New +$62.4K ﹤0.01% 3308
2025
Q1
Sell
-10,526
Closed -$18.9K 2494
2024
Q4
$18.9K Sell
10,526
-2,569
-20% -$4.79K ﹤0.01% 2052
2024
Q3
$28K Sell
13,095
-2,225
-15% -$4.83K ﹤0.01% 1787
2024
Q2
$28.6K Buy
+15,320
New +$40.2K ﹤0.01% 1574

Other funds holding CLLS

XTX Topco's CLLS Position: Q2 2026 in Review

XTX Topco reduced its Cellectis (CLLS) stake by 25% in Q2 2026, selling an estimated $14.2K and leaving 12,282 shares worth $36.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3781.

XTX Topco first reported a position in CLLS in Q2 2024 and has held it in 5 quarters since. The position peaked at $51.6K in Q1 2026. 27 funds tracked by Wall St. Rank hold CLLS as of Q2 2026.

  • XTX Topco held 12,282 shares of Cellectis worth $36.8K as of Q2 2026.
  • XTX Topco sold 3,987 Cellectis shares in Q2 2026, an estimated $14.2K.
  • Cellectis made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3781 holding.
  • XTX Topco first reported a position in Cellectis in Q2 2024 and has held it in 5 quarters since.
  • XTX Topco's Cellectis position peaked at $51.6K in Q1 2026.
  • 27 funds tracked by Wall St. Rank held Cellectis as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.